SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Xencor (XNCR)
An SI Board Since January 2014
Posts SubjectMarks Bans Symbol
136 22 0 XNCR
Emcee:  scaram(o)uche Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
61thanks for sharing, I only have a small lot, toe in the water so to speak. not mopgcw-12/17/2014
60I just sold 1/3 of my position, but will repurchase it on ANY weakness.scaram(o)uche-12/17/2014
59Take profits here ahead of the RA news??? RA has been such a disaster for me...mopgcw-12/17/2014
58>> second CD123 shot on goal still sitting there, waiting for preclinical scaram(o)uche-11/8/2014
57Low hanging fruit, but thanks. Best! Rickscaram(o)uche-11/7/2014
56A prescient observation in your earlier post!fitzdad55-11/7/2014
55>> second CD123 shot on goal still sitting there, waiting for preclinical scaram(o)uche-11/6/2014
54that slide from Mike Magee ?@MichaelSMagee Aug 21the role of Fc receptors in tscaram(o)uche-10/31/2014
53[graphic]scaram(o)uche110/31/2014
52"I just don't expect results which point to commercial viability."fitzdad55-10/30/2014
51>> I wouldn't jump to the conclusion that Ph2a data for 5871 in RA is scaram(o)uche-10/30/2014
50I wouldn't jump to the conclusion that Ph2a data for 5871 in RA is going to fitzdad55-10/30/2014
49RIghto, thanks!tuck-10/29/2014
48Already covered here, sounded like MOR208 data could come early.scaram(o)uche-10/29/2014
47Are we going to see anything good before the data reads out? If not, why shouldtuck-10/29/2014
46Given (1) 7195 (IgE variable/IIb Immune Inhibitor Fc), and (2) 5871 now pointed scaram(o)uche-10/29/2014
45Never given a FF about Amgen and RA, and still don't. ALWAYS have considerescaram(o)uche-10/29/2014
44" poor RA data might be a blessing." Disagree. It's still an asstuck-10/29/2014
43>> It does seem to mark a more intensive focus on mAb therapies for diseasscaram(o)uche-10/29/2014
42>> Apparently, Xencor & Amgen do, too, a little bit. << Agreed.scaram(o)uche-10/29/2014
41This has to be one of the most boring trading stocks in biotech. I haven't tuck-10/29/2014
40An interesting move by Dahiyat. Because the ph2a trial for XmaB5871 was blinded fitzdad55-10/28/2014
39>> First, they certainly have addressed Tuck's recent concern! <<scaram(o)uche-10/28/2014
38Pipeline chart updated, second CD123 shot on goal still sitting there, waiting fscaram(o)uche-10/28/2014
37Lots going on here today. First, they certainly have addressed Tuck's recenscaram(o)uche110/28/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News